509 related articles for article (PubMed ID: 20960377)
41. Possible molecular mechanisms soy-mediated in preventing and treating nonalcoholic fatty liver disease.
Oliveira LP; de Jesús RP; Freire TO; Oliveira CP; Castro Lyra A; Lyra LG
Nutr Hosp; 2012; 27(4):991-8. PubMed ID: 23165534
[TBL] [Abstract][Full Text] [Related]
42. Betaine attenuates chronic alcohol‑induced fatty liver by broadly regulating hepatic lipid metabolism.
Yang W; Huang L; Gao J; Wen S; Tai Y; Chen M; Huang Z; Liu R; Tang C; Li J
Mol Med Rep; 2017 Oct; 16(4):5225-5234. PubMed ID: 28849079
[TBL] [Abstract][Full Text] [Related]
43. The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease.
Polyzos SA; Kountouras J; Zavos C; Tsiaousi E
Diabetes Obes Metab; 2010 May; 12(5):365-83. PubMed ID: 20415685
[TBL] [Abstract][Full Text] [Related]
44. Role of AMP-activated protein kinase and adiponectin during development of hepatic steatosis in high-fat diet-induced obesity in rats.
Ha SK; Kim J; Chae C
J Comp Pathol; 2011 Jul; 145(1):88-94. PubMed ID: 21255792
[TBL] [Abstract][Full Text] [Related]
45. Role of fatty liver, dietary fatty acid supplements, and obesity in the progression of alcoholic liver disease: introduction and summary of the symposium.
Purohit V; Russo D; Coates PM
Alcohol; 2004 Aug; 34(1):3-8. PubMed ID: 15670659
[TBL] [Abstract][Full Text] [Related]
46. Lipid in the livers of adolescents with nonalcoholic steatohepatitis: combined effects of pathways on steatosis.
Zhu L; Baker SS; Liu W; Tao MH; Patel R; Nowak NJ; Baker RD
Metabolism; 2011 Jul; 60(7):1001-11. PubMed ID: 21075404
[TBL] [Abstract][Full Text] [Related]
47. The importance of the long-chain polyunsaturated fatty acid n-6/n-3 ratio in development of non-alcoholic fatty liver associated with obesity.
Valenzuela R; Videla LA
Food Funct; 2011 Nov; 2(11):644-8. PubMed ID: 22008843
[TBL] [Abstract][Full Text] [Related]
48. Aging is associated with a shift of fatty metabolism toward lipogenesis.
Kuhla A; Blei T; Jaster R; Vollmar B
J Gerontol A Biol Sci Med Sci; 2011 Nov; 66(11):1192-200. PubMed ID: 21835806
[TBL] [Abstract][Full Text] [Related]
49. The adiponectin-SIRT1-AMPK pathway in alcoholic fatty liver disease in the rat.
Jiang Z; Zhou J; Zhou D; Zhu Z; Sun L; Nanji AA
Alcohol Clin Exp Res; 2015 Mar; 39(3):424-33. PubMed ID: 25703252
[TBL] [Abstract][Full Text] [Related]
50. Endoplasmic reticulum stress in nonalcoholic fatty liver disease.
Pagliassotti MJ
Annu Rev Nutr; 2012 Aug; 32():17-33. PubMed ID: 22809102
[TBL] [Abstract][Full Text] [Related]
51. Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis.
Lieber CS
Alcohol; 2004 Aug; 34(1):9-19. PubMed ID: 15670660
[TBL] [Abstract][Full Text] [Related]
52. α-Terpineol induces fatty liver in mice mediated by the AMP-activated kinase and sterol response element binding protein pathway.
Choi YJ; Sim WC; Choi HK; Lee SH; Lee BH
Food Chem Toxicol; 2013 May; 55():129-36. PubMed ID: 23274539
[TBL] [Abstract][Full Text] [Related]
53. Adverse signaling of scavenger receptor class B1 and PGC1s in alcoholic hepatosteatosis and steatohepatitis and protection by betaine in rat.
Varatharajalu R; Garige M; Leckey LC; Arellanes-Robledo J; Reyes-Gordillo K; Shah R; Lakshman MR
Am J Pathol; 2014 Jul; 184(7):2035-44. PubMed ID: 24814604
[TBL] [Abstract][Full Text] [Related]
54. Microsomal triglyceride transfer protein and nonalcoholic fatty liver disease.
Pereira IV; Stefano JT; Oliveira CP
Expert Rev Gastroenterol Hepatol; 2011 Apr; 5(2):245-51. PubMed ID: 21476919
[TBL] [Abstract][Full Text] [Related]
55. Regulation of fat metabolism in the liver: link to non-alcoholic hepatic steatosis and impact of physical exercise.
Lavoie JM; Gauthier MS
Cell Mol Life Sci; 2006 Jun; 63(12):1393-409. PubMed ID: 16649140
[TBL] [Abstract][Full Text] [Related]
56. Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice.
You M; Considine RV; Leone TC; Kelly DP; Crabb DW
Hepatology; 2005 Sep; 42(3):568-77. PubMed ID: 16108051
[TBL] [Abstract][Full Text] [Related]
57. Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease.
Begriche K; Massart J; Robin MA; Bonnet F; Fromenty B
Hepatology; 2013 Oct; 58(4):1497-507. PubMed ID: 23299992
[TBL] [Abstract][Full Text] [Related]
58. Mitochondrial dysfunction in nonalcoholic steatohepatitis.
Serviddio G; Bellanti F; Vendemiale G; Altomare E
Expert Rev Gastroenterol Hepatol; 2011 Apr; 5(2):233-44. PubMed ID: 21476918
[TBL] [Abstract][Full Text] [Related]
59. Organelle dysfunction in hepatitis C virus-associated steatosis: anything to learn from nonalcoholic steatohepatitis?
Pattullo V; Douglas MW; George J
Expert Rev Gastroenterol Hepatol; 2011 Apr; 5(2):265-77. PubMed ID: 21476921
[TBL] [Abstract][Full Text] [Related]
60. Effects of ethanol on lipid metabolism.
Baraona E; Lieber CS
J Lipid Res; 1979 Mar; 20(3):289-315. PubMed ID: 87483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
